CryoPort financials
$17.32−0.35%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $49.0M | $47.8M | $45.5M | $44.2M | $45.5M | $41.0M | $41.5M | $38.3M | $39.7M | $37.3M | $57.3M | $56.2M |
| Gross profit | $22.8M | $21.9M | $21.7M | $21.3M | $21.4M | $18.6M | $19.5M | $17.4M | $17.7M | $15.1M | $23.3M | $24.3M |
| Gross margin | 46.6% | 45.8% | 47.8% | 48.2% | 47.0% | 45.4% | 47.0% | 45.5% | 44.5% | 40.4% | 40.6% | 43.2% |
| Operating income | -$10.0M | -$9.6M | -$10.0M | -$9.9M | -$9.6M | -$7.2M | -$12.7M | -$13.4M | -$78.0M | -$17.5M | -$69.9M | -$16.9M |
| Net income | -$10.3M | -$12.5M | -$13.6M | -$8.9M | $106.9M | -$14.0M | -$20.7M | -$1.2M | -$80.0M | -$20.9M | -$64.4M | -$15.3M |
| Net margin | −20.9% | −26.2% | −30.0% | −20.2% | 235.1% | −34.1% | −49.9% | −3.1% | −201.4% | −56.0% | −112.5% | −27.2% |
| Diluted EPS | $-0.20 | $-0.25 | $-0.27 | $-0.18 | $2.13 | $-0.28 | $-0.42 | $-0.02 | $-1.62 | $-0.43 | $-1.31 | $-0.31 |
| EBITDA | -$3.5M | -$3.2M | -$3.7M | -$3.5M | -$2.4M | $452.0K | -$4.9M | -$5.6M | -$6.7M | -$10.0M | -$12.9M | -$10.0M |
| Operating cash flow | $1.1M | $3.7M | $919.0K | $2.2M | -$7.3M | -$4.3M | -$5.5M | $447.0K | -$7.7M | -$3.6M | $2.3M | -$1.8M |
| Free cash flow | -$8.0M | -$6.2M | -$4.5M | -$1.3M | -$11.7M | -$7.5M | -$10.7M | -$3.8M | -$11.5M | -$7.6M | -$9.3M | -$11.8M |
| Diluted shares | 50.4M | 49.9M | 50.0M | 50.1M | 50.3M | 49.9M | 49.6M | 49.4M | 49.3M | 49.0M | 49.0M | 48.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $269.3M | $272.9M | $250.5M | $255.8M | $243.4M | $36.1M |
| Short-term investments | $127.4M | $130.7M | $160.7M | $165.5M | $182.6M | $207.9M |
| Total debt | $188.0M | $187.7M | $187.5M | $187.4M | $187.2M | $200.9M |
| Total assets | $756.2M | $763.6M | $765.0M | $774.3M | $773.9M | $699.8M |
| Total liabilities | $265.5M | $268.6M | $262.4M | $261.1M | $258.5M | $301.0M |
| Shareholders' equity | $490.7M | $495.0M | $502.6M | $513.3M | $515.4M | $398.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology